Dealings in securities by directors and prescribed officers of the company ELLIES HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (Registration number: 2007/007084/06) JSE share code: ELI ISIN: ZAE000103081 ("Ellies" or the "Company") DEALINGS IN SECURITIES BY DIRECTORS AND PRESCRIBED OFFICERS OF THE COMPANY Shareholders are advised of the following information relating to dealings in securities by directors of Ellies pursuant to the Ellies Holdings Limited Long Term Incentive Plan ("LTI Plan") which shares will vest, subject to certain performance conditions, on 28 April 2025: Name of director: Shaun Prithivirajh Date of transaction: 29 April 2022 Class of securities: Ordinary shares Number of securities: 6 408 494 Price per security: RNil Total deemed value of transaction: R1 409 868.68, being the total deemed value calculated using the closing price of Ellies shares on 27 April 2022 of R0.22 Nature of transaction: Off-market grant and acceptance of awards under the terms of the LTI Plan Nature and extent of director's interest: Direct beneficial Clearance to deal received: Yes Name of director: Guy Moretti Date of transaction: 29 April 2022 Class of securities: Ordinary shares Number of securities: 2 944 444 Price per security: RNil Total deemed value of transaction: R 647 777.68, being the total deemed value calculated using the closing price of Ellies shares on 27 April 2022 of R0.22 Nature of transaction: Off-market grant and acceptance of awards under the terms of the LTI Plan Nature and extent of director's interest: Direct beneficial Clearance to deal received: Yes Name of prescribed officer: Zeyn Agjee Date of transaction: 29 April 2022 Class of securities: Ordinary shares Number of securities: 2 136 960 Price per security: RNil Total deemed value of transaction: R 470 131.20, being the total deemed value calculated using the closing price of Ellies shares on 27 April 2022 of R0.22 Nature of transaction: Off-market grant and acceptance of awards under the terms of the LTI Plan Nature and extent of prescribed officer's interest: Direct beneficial Clearance to deal received: Yes Name of prescribed officer: Johannes Klein Date of transaction: 29 April 2022 Class of securities: Ordinary shares Number of securities: 2 183 090 Price per security: RNil Total deemed value of transaction: R 480 279.80, being the total deemed value calculated using the closing price of Ellies shares on 27 April 2022 of R0.22 Nature of transaction: Off-market grant and acceptance of awards under the terms of the LTI Plan Nature and extent of prescribed officer's interest: Direct beneficial Clearance to deal received: Yes 5 May 2022 Sponsor Java Capital Date: 05-05-2022 03:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.